Company · CIK 0001799850
Renovacor, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13D/ARenovacor, Inc.0000902664-23-002480 · 45.8 KBSEC(opens sec.gov)
- SC 13G/ARenovacor, Inc.0001104659-23-020660 · 135.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-22-296600 · 286.2 KBSEC(opens sec.gov)
- 10-QQuarterly update0000950170-22-024481 · 11.5 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-22-262581 · 16.7 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-22-249253 · 17.0 MBSEC(opens sec.gov)
- SC 13DRenovacor, Inc.0000902664-22-004311 · 62.7 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-22-247756 · 1.1 MBSEC(opens sec.gov)
- 10-QQuarterly update0000950170-22-015543 · 10.6 MBSEC(opens sec.gov)
- 8-KCurrent report0000950170-22-015534 · 437.4 KBSEC(opens sec.gov)
Insiders
- Amusa GbolahanDirector
- Barudin GuyChief Operating Officer
- Benz Edward J. JRDirector
- Carroll Joseph SChief Accounting Officer
- Cook MagdaleneDirector, Chief Executive Officer
- COVINO GREGORY FDirector
- DICICCO WENDY FChief Financial Officer
- DRISCOLL FREDERICK WChief Financial Officer
- Giroux RichardDirector
- GROSSMAN JONASDirector
Tickers
No tickers on record.
Addresses
business
201 BROADWAY SUITE 310
CAMBRIDGE, MA, 02139
mailing
201 BROADWAY SUITE 310
CAMBRIDGE, MA, 02139
Former names
- Chardan Healthcare Acquisition 2 Corp.2021-09-03
- Chardan Healthcare Acquisition III Corp.2020-01-16
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies